Phase 4 HIV Clinical Trials
28 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 28 trials
Recruiting
Phase 4
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
HIVSubstance Use Disorder (SUD)Injection Drug Use
Massachusetts General Hospital100 enrolled2 locationsNCT07199335
Recruiting
Phase 4
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
HIV-1-infection
Gilead Sciences350 enrolled14 locationsNCT06337032
Recruiting
Phase 4
Doravirine Dose Optimisation in Pregnancy
HIV
University of Liverpool76 enrolled1 locationNCT05630638
Recruiting
Phase 4
OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa
MalariaHIV
Yale University380 enrolled2 locationsNCT06967519
Recruiting
Phase 4
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
HIV Prevention and CareHIV PreventionHIV Prevention Program+2 more
Duke University100 enrolled1 locationNCT07218211
Recruiting
Phase 4
MAPS PrEP Van Study
HIV Infection
Duke University20 enrolled1 locationNCT06908252
Recruiting
Phase 4
HIV Prevention With PrEP Among People on Opioid Replacement Therapy
HIV (Human Immunodeficiency Virus)
Cara Spence350 enrolled6 locationsNCT07160075
Recruiting
Phase 4
Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting
HIV
Kelley-Ross & Associates, Inc.75 enrolled1 locationNCT07210125
Recruiting
Phase 4
Zoledronic Acid for the Prevention of TDF-sparing ART-induced Bone Mass Density Loss in Treatment-naive HIV Positive Individuals
OsteopeniaHIV Infected Individuals
Hadassah Medical Organization110 enrolled3 locationsNCT06762730
Recruiting
Phase 4
Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH)
HIVHIV-1
UBATEC50 enrolled1 locationNCT06967753
Recruiting
Phase 4
Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up
HIV Infections
José Antonio Mata Marín156 enrolled1 locationNCT07138144
Recruiting
Phase 4
HIV Prevention and Care Interventions for Youth in Uganda
HIV
MU-JHU CARE600 enrolled1 locationNCT06474364
Recruiting
Phase 4
Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention
HIV
University of Alabama at Birmingham1,400 enrolled1 locationNCT07076043
Recruiting
Phase 4
Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience
Metabolic SyndromeHIV InfectionAntiretroviral Treatment
Instituto Mexicano del Seguro Social124 enrolled1 locationNCT07031063
Recruiting
Phase 4
Vaccine Immunity and Inflammation in the Aging Person Living With HIV
AgeHIV Infections
Hennepin Healthcare Research Institute250 enrolled1 locationNCT06514547
Recruiting
Phase 4
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
Smoking CessationHuman Immunodeficiency Virus (HIV)
New York University500 enrolled1 locationNCT06598397
Recruiting
Phase 4
Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
Opioid-use DisorderHIVeHealth
Yale University250 enrolled2 locationsNCT05547048
Recruiting
Phase 4
Accelerated ART Initiation for PWHIV Who Are Out of Care
HIV InfectionsARTNoncompliance, Patient
University of Missouri-Columbia120 enrolled4 locationsNCT06374758
Recruiting
Phase 4
Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use
Immune DysregulationHIVSystemic Inflammation+1 more
University of Alabama at Birmingham100 enrolled1 locationNCT06829238
Recruiting
Phase 4
Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico
HIV Infection
José Antonio Mata Marín138 enrolled1 locationNCT06907056